Global Endometriosis Therapies Market Research Report 2024

Report ID: 1897818 | Published Date: Sep 2024 | No. of Page: 87 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Endometriosis Therapies Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Hormonal Contraceptives
        1.2.3 Gonadotropin-releasingHormone(Gn-RH)Agonists
        1.2.4 Progestin Therapy
        1.2.5 Aromatase Inhibitors
    1.3 Market by Application
        1.3.1 Global Endometriosis Therapies Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Endometriosis Therapies Market Perspective (2017-2028)
    2.2 Endometriosis Therapies Growth Trends by Region
        2.2.1 Endometriosis Therapies Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Endometriosis Therapies Historic Market Size by Region (2017-2022)
        2.2.3 Endometriosis Therapies Forecasted Market Size by Region (2023-2028)
    2.3 Endometriosis Therapies Market Dynamics
        2.3.1 Endometriosis Therapies Industry Trends
        2.3.2 Endometriosis Therapies Market Drivers
        2.3.3 Endometriosis Therapies Market Challenges
        2.3.4 Endometriosis Therapies Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Endometriosis Therapies Players by Revenue
        3.1.1 Global Top Endometriosis Therapies Players by Revenue (2017-2022)
        3.1.2 Global Endometriosis Therapies Revenue Market Share by Players (2017-2022)
    3.2 Global Endometriosis Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Endometriosis Therapies Revenue
    3.4 Global Endometriosis Therapies Market Concentration Ratio
        3.4.1 Global Endometriosis Therapies Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Endometriosis Therapies Revenue in 2021
    3.5 Endometriosis Therapies Key Players Head office and Area Served
    3.6 Key Players Endometriosis Therapies Product Solution and Service
    3.7 Date of Enter into Endometriosis Therapies Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Endometriosis Therapies Breakdown Data by Type
    4.1 Global Endometriosis Therapies Historic Market Size by Type (2017-2022)
    4.2 Global Endometriosis Therapies Forecasted Market Size by Type (2023-2028)
5 Endometriosis Therapies Breakdown Data by Application
    5.1 Global Endometriosis Therapies Historic Market Size by Application (2017-2022)
    5.2 Global Endometriosis Therapies Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Endometriosis Therapies Market Size (2017-2028)
    6.2 North America Endometriosis Therapies Market Size by Country (2017-2022)
    6.3 North America Endometriosis Therapies Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Endometriosis Therapies Market Size (2017-2028)
    7.2 Europe Endometriosis Therapies Market Size by Country (2017-2022)
    7.3 Europe Endometriosis Therapies Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Endometriosis Therapies Market Size (2017-2028)
    8.2 Asia-Pacific Endometriosis Therapies Market Size by Country (2017-2022)
    8.3 Asia-Pacific Endometriosis Therapies Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Endometriosis Therapies Market Size (2017-2028)
    9.2 Latin America Endometriosis Therapies Market Size by Country (2017-2022)
    9.3 Latin America Endometriosis Therapies Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Endometriosis Therapies Market Size (2017-2028)
    10.2 Middle East & Africa Endometriosis Therapies Market Size by Country (2017-2022)
    10.3 Middle East & Africa Endometriosis Therapies Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Detail
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Endometriosis Therapies Introduction
        11.1.4 AbbVie Revenue in Endometriosis Therapies Business (2017-2022)
        11.1.5 AbbVie Recent Development
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Detail
        11.2.2 Eli Lilly Business Overview
        11.2.3 Eli Lilly Endometriosis Therapies Introduction
        11.2.4 Eli Lilly Revenue in Endometriosis Therapies Business (2017-2022)
        11.2.5 Eli Lilly Recent Development
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Detail
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Endometriosis Therapies Introduction
        11.3.4 AstraZeneca Revenue in Endometriosis Therapies Business (2017-2022)
        11.3.5 AstraZeneca Recent Development
    11.4 Bayer
        11.4.1 Bayer Company Detail
        11.4.2 Bayer Business Overview
        11.4.3 Bayer Endometriosis Therapies Introduction
        11.4.4 Bayer Revenue in Endometriosis Therapies Business (2017-2022)
        11.4.5 Bayer Recent Development
    11.5 Astellas Pharma
        11.5.1 Astellas Pharma Company Detail
        11.5.2 Astellas Pharma Business Overview
        11.5.3 Astellas Pharma Endometriosis Therapies Introduction
        11.5.4 Astellas Pharma Revenue in Endometriosis Therapies Business (2017-2022)
        11.5.5 Astellas Pharma Recent Development
    11.6 Meditrina Pharmaceuticals
        11.6.1 Meditrina Pharmaceuticals Company Detail
        11.6.2 Meditrina Pharmaceuticals Business Overview
        11.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Introduction
        11.6.4 Meditrina Pharmaceuticals Revenue in Endometriosis Therapies Business (2017-2022)
        11.6.5 Meditrina Pharmaceuticals Recent Development
    11.7 Pfizer
        11.7.1 Pfizer Company Detail
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Endometriosis Therapies Introduction
        11.7.4 Pfizer Revenue in Endometriosis Therapies Business (2017-2022)
        11.7.5 Pfizer Recent Development
    11.8 Neurocrine Biosciences
        11.8.1 Neurocrine Biosciences Company Detail
        11.8.2 Neurocrine Biosciences Business Overview
        11.8.3 Neurocrine Biosciences Endometriosis Therapies Introduction
        11.8.4 Neurocrine Biosciences Revenue in Endometriosis Therapies Business (2017-2022)
        11.8.5 Neurocrine Biosciences Recent Development
    11.9 Takeda Pharmaceutical
        11.9.1 Takeda Pharmaceutical Company Detail
        11.9.2 Takeda Pharmaceutical Business Overview
        11.9.3 Takeda Pharmaceutical Endometriosis Therapies Introduction
        11.9.4 Takeda Pharmaceutical Revenue in Endometriosis Therapies Business (2017-2022)
        11.9.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Endometriosis Therapies Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Hormonal Contraceptives
    Table 3. Key Players of Gonadotropin-releasingHormone(Gn-RH)Agonists
    Table 4. Key Players of Progestin Therapy
    Table 5. Key Players of Aromatase Inhibitors
    Table 6. Global Endometriosis Therapies Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Endometriosis Therapies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Endometriosis Therapies Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Endometriosis Therapies Market Share by Region (2017-2022)
    Table 10. Global Endometriosis Therapies Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Endometriosis Therapies Market Share by Region (2023-2028)
    Table 12. Endometriosis Therapies Market Trends
    Table 13. Endometriosis Therapies Market Drivers
    Table 14. Endometriosis Therapies Market Challenges
    Table 15. Endometriosis Therapies Market Restraints
    Table 16. Global Endometriosis Therapies Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Endometriosis Therapies Market Share by Players (2017-2022)
    Table 18. Global Top Endometriosis Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Therapies as of 2021)
    Table 19. Ranking of Global Top Endometriosis Therapies Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Endometriosis Therapies Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Endometriosis Therapies Product Solution and Service
    Table 23. Date of Enter into Endometriosis Therapies Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Endometriosis Therapies Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Endometriosis Therapies Revenue Market Share by Type (2017-2022)
    Table 27. Global Endometriosis Therapies Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Endometriosis Therapies Revenue Market Share by Type (2023-2028)
    Table 29. Global Endometriosis Therapies Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Endometriosis Therapies Revenue Market Share by Application (2017-2022)
    Table 31. Global Endometriosis Therapies Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Endometriosis Therapies Revenue Market Share by Application (2023-2028)
    Table 33. North America Endometriosis Therapies Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Endometriosis Therapies Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Endometriosis Therapies Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Endometriosis Therapies Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Endometriosis Therapies Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Endometriosis Therapies Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Endometriosis Therapies Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Endometriosis Therapies Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Endometriosis Therapies Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Endometriosis Therapies Market Size by Country (2023-2028) & (US$ Million)
    Table 43. AbbVie Company Detail
    Table 44. AbbVie Business Overview
    Table 45. AbbVie Endometriosis Therapies Product
    Table 46. AbbVie Revenue in Endometriosis Therapies Business (2017-2022) & (US$ Million)
    Table 47. AbbVie Recent Development
    Table 48. Eli Lilly Company Detail
    Table 49. Eli Lilly Business Overview
    Table 50. Eli Lilly Endometriosis Therapies Product
    Table 51. Eli Lilly Revenue in Endometriosis Therapies Business (2017-2022) & (US$ Million)
    Table 52. Eli Lilly Recent Development
    Table 53. AstraZeneca Company Detail
    Table 54. AstraZeneca Business Overview
    Table 55. AstraZeneca Endometriosis Therapies Product
    Table 56. AstraZeneca Revenue in Endometriosis Therapies Business (2017-2022) & (US$ Million)
    Table 57. AstraZeneca Recent Development
    Table 58. Bayer Company Detail
    Table 59. Bayer Business Overview
    Table 60. Bayer Endometriosis Therapies Product
    Table 61. Bayer Revenue in Endometriosis Therapies Business (2017-2022) & (US$ Million)
    Table 62. Bayer Recent Development
    Table 63. Astellas Pharma Company Detail
    Table 64. Astellas Pharma Business Overview
    Table 65. Astellas Pharma Endometriosis Therapies Product
    Table 66. Astellas Pharma Revenue in Endometriosis Therapies Business (2017-2022) & (US$ Million)
    Table 67. Astellas Pharma Recent Development
    Table 68. Meditrina Pharmaceuticals Company Detail
    Table 69. Meditrina Pharmaceuticals Business Overview
    Table 70. Meditrina Pharmaceuticals Endometriosis Therapies Product
    Table 71. Meditrina Pharmaceuticals Revenue in Endometriosis Therapies Business (2017-2022) & (US$ Million)
    Table 72. Meditrina Pharmaceuticals Recent Development
    Table 73. Pfizer Company Detail
    Table 74. Pfizer Business Overview
    Table 75. Pfizer Endometriosis Therapies Product
    Table 76. Pfizer Revenue in Endometriosis Therapies Business (2017-2022) & (US$ Million)
    Table 77. Pfizer Recent Development
    Table 78. Neurocrine Biosciences Company Detail
    Table 79. Neurocrine Biosciences Business Overview
    Table 80. Neurocrine Biosciences Endometriosis Therapies Product
    Table 81. Neurocrine Biosciences Revenue in Endometriosis Therapies Business (2017-2022) & (US$ Million)
    Table 82. Neurocrine Biosciences Recent Development
    Table 83. Takeda Pharmaceutical Company Detail
    Table 84. Takeda Pharmaceutical Business Overview
    Table 85. Takeda Pharmaceutical Endometriosis Therapies Product
    Table 86. Takeda Pharmaceutical Revenue in Endometriosis Therapies Business (2017-2022) & (US$ Million)
    Table 87. Takeda Pharmaceutical Recent Development
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Endometriosis Therapies Market Share by Type: 2021 VS 2028
    Figure 2. Hormonal Contraceptives Features
    Figure 3. Gonadotropin-releasingHormone(Gn-RH)Agonists Features
    Figure 4. Progestin Therapy Features
    Figure 5. Aromatase Inhibitors Features
    Figure 6. Global Endometriosis Therapies Market Share by Application in 2021 & 2028
    Figure 7. Hospital Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Other Case Studies
    Figure 10. Endometriosis Therapies Report Years Considered
    Figure 11. Global Endometriosis Therapies Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Endometriosis Therapies Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Endometriosis Therapies Market Share by Region: 2021 VS 2028
    Figure 14. Global Endometriosis Therapies Market Share by Players in 2021
    Figure 15. Global Top Endometriosis Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Therapies as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Endometriosis Therapies Revenue in 2021
    Figure 17. North America Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Endometriosis Therapies Market Share by Country (2017-2028)
    Figure 19. United States Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Endometriosis Therapies Market Share by Country (2017-2028)
    Figure 23. Germany Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Endometriosis Therapies Market Share by Region (2017-2028)
    Figure 31. China Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Endometriosis Therapies Market Share by Country (2017-2028)
    Figure 39. Mexico Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Endometriosis Therapies Market Share by Country (2017-2028)
    Figure 43. Turkey Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Endometriosis Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. AbbVie Revenue Growth Rate in Endometriosis Therapies Business (2017-2022)
    Figure 46. Eli Lilly Revenue Growth Rate in Endometriosis Therapies Business (2017-2022)
    Figure 47. AstraZeneca Revenue Growth Rate in Endometriosis Therapies Business (2017-2022)
    Figure 48. Bayer Revenue Growth Rate in Endometriosis Therapies Business (2017-2022)
    Figure 49. Astellas Pharma Revenue Growth Rate in Endometriosis Therapies Business (2017-2022)
    Figure 50. Meditrina Pharmaceuticals Revenue Growth Rate in Endometriosis Therapies Business (2017-2022)
    Figure 51. Pfizer Revenue Growth Rate in Endometriosis Therapies Business (2017-2022)
    Figure 52. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Therapies Business (2017-2022)
    Figure 53. Takeda Pharmaceutical Revenue Growth Rate in Endometriosis Therapies Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Eli Lilly
AstraZeneca
Bayer
Astellas Pharma
Meditrina Pharmaceuticals
Pfizer
Neurocrine Biosciences
Takeda Pharmaceutical
Frequently Asked Questions
Endometriosis Therapies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Endometriosis Therapies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Endometriosis Therapies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports